Proresolving lipid mediators: potential for prevention and treatment of periodontitis (Q37842643)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21323709%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

review article

1 reference

title

Proresolving lipid mediators: potential for prevention and treatment of periodontitis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21323709%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21323709%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Thomas E Van Dyke

1 reference

24 August 2017

language of work or name

English

0 references

publication date

1 March 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21323709%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

March 2011

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21323709

full work available at URL

24 November 2024

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1600-051X.2010.01662.x

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21323709

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1600-051X.2010.01662.x

24 November 2024

1 reference

DOI

https://api.crossref.org/works/10.1111/J.1600-051X.2010.01662.X

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1600-051X.2010.01662.x

24 November 2024

1 reference

DOI

https://api.crossref.org/works/10.1111/J.1600-051X.2010.01662.X

Journal of Clinical Periodontology

24 November 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21323709%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

volume

38 Suppl 11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21323709%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

page(s)

119-125

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21323709%20AND%20SRC:MED&resulttype=core&format=json

Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico

22 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01662.X

Blood levels of long-chain n-3 fatty acids and the risk of sudden death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01662.X

Apoptotic neutrophils and T cells sequester chemokines during immune response resolution through modulation of CCR5 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01662.X

Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01662.X

Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01662.X

Molecular circuits of resolution: formation and actions of resolvins and protectins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01662.X

The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01662.X

Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01662.X

Periodontitis: a polymicrobial disruption of host homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01662.X

Adjunctive treatment of chronic periodontitis with daily dietary supplementation with omega-3 Fatty acids and low-dose aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01662.X

Resolvin E1 regulates inflammation at the cellular and tissue level and restores tissue homeostasis in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01662.X

Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01662.X

Neutrophil-mediated tissue injury in periodontal disease pathogenesis: findings from localized aggressive periodontitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01662.X

Lipid mediator class switching during acute inflammation: signals in resolution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01662.X

Expression of BPI (bactericidal/permeability-increasing protein) in human mucosal epithelia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01662.X

Lipoxin A4 stable analogs are potent mimetics that stimulate human monocytes and THP-1 cells via a G-protein-linked lipoxin A4 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01662.X

Lipoxin A4 and B4 are potent stimuli for human monocyte migration and adhesion: selective inactivation by dehydrogenation and reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01662.X

Lipoxins, aspirin-triggered epi-lipoxins, lipoxin stable analogues, and the resolution of inflammation: stimulation of macrophage phagocytosis of apoptotic neutrophils in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01662.X

Resolvin E1 and protectin D1 activate inflammation-resolution programmes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01662.X

Lipoxin biosynthesis and its impact in inflammatory and vascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01662.X

Novel omega -- 3-derived local mediators in anti-inflammation and resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01662.X

Resolution of inflammation: state of the art, definitions and terms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01662.X

Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01662.X

Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01662.X

Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01662.X

Design of lipoxin A4 stable analogs that block transmigration and adhesion of human neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01662.X

Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01662.X

Evidence of bacterial etiology: a historical perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01662.X

Dental biofilms: difficult therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01662.X

Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01662.X

Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01662.X

Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01662.X

Control of inflammation and periodontitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01662.X

The management of inflammation in periodontal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01662.X

Resolution of inflammation: a new paradigm for the pathogenesis of periodontal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-051X.2010.01662.X

Augmentation of myocardial production of 15-epi-lipoxin-a4 by pioglitazone and atorvastatin in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-051X.2010.01662.X

Aspirin-triggered lipoxins (15-epi-LX) are generated by the human lung adenocarcinoma cell line (A549)-neutrophil interactions and are potent inhibitors of cell proliferation.

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-051X.2010.01662.X

Vascular prostacyclin is increased in patients ingesting omega-3 polyunsaturated fatty acids before coronary artery bypass graft surgery

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-051X.2010.01662.X

COX-2 in play at the AHA and the FDA

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-051X.2010.01662.X

RvE1 protects from local inflammation and osteoclast- mediated bone destruction in periodontitis

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-051X.2010.01662.X

Nonsteroidal antiinflammatory drugs as inhibitors of periodontal disease progression

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-051X.2010.01662.X

The effect of fluoride on the stability of oral bacterial communities in vitro

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-051X.2010.01662.X

Lipoxin A4Analogues Inhibit Leukocyte Recruitment toPorphyromonas gingivalis: A Role for Cyclooxygenase-2 and Lipoxins in Periodontal Disease†

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-051X.2010.01662.X

Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-051X.2010.01662.X

Lipoxin A4 metabolism by differentiated HL-60 cells and human monocytes: conversion to novel 15-oxo and dihydro products

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-051X.2010.01662.X

Clinical characteristics and microbiota of progressing slight chronic periodontitis in adults

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-051X.2010.01662.X

Topical flurbiprofen treatment of periodontitis in beagles

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-051X.2010.01662.X

24 November 2024

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21323709%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21323709%20AND%20SRC:MED&resulttype=core&format=json